Specify a stock or a cryptocurrency in the search bar to get a summary
Sihuan Pharmaceutical Holdings Group Ltd
0460Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China. The company operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. It offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthetics comprehensive solutions. It offers drugs in the oncology, metabolism, diabetes, cardiovascular and cerebrovascular, modern Chinese medicine, and industrial hemp therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, and biotechnology and technology promotion services. Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong. Address: Office Tower, Convention Plaza, Wan Chai, Hong Kong
Analytics
WallStreet Target Price
21.33 HKDP/E ratio
–Dividend Yield
3.14 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 0460
Dividend Analytics 0460
Dividend growth over 5 years
76 %Continuous growth
3 yearsPayout Ratio 5 years average
-108 %Dividend History 0460
Stock Valuation 0460
Financials 0460
Results | 2019 | Dynamics |